Navigation Links
NTU and Sembcorp to jointly explore novel waste water treatment technology
Date:6/24/2009

Nanyang Technological University's Nanyang Environment and Water Research Institute (NTU-NEWRI) and Sembcorp Industries (Sembcorp) signed an agreement today to jointly explore the application of a new system for the treatment of complex industrial wastewater.

Under the agreement, Sembcorp and NTU-NEWRI will work together over the next three years to explore a novel treatment technology aimed at removing recalcitrant organic matter from wastewater. These recalcitrant organic substances are characterised by poor biodegradability and by their difficulty of removal though the biological wastewater treatment process. The project would be supervised by researchers from NTU-NEWRI as well as water experts from Sembcorp. Intellectual property rights would be jointly shared by Sembcorp and NTU-NEWRI and Sembcorp will invest an estimated $1 million in the project.

The agreement was signed at Singapore International Water Week (SIWW) 2009 by Mr Tan Cheng Guan, Sembcorp Industries' Executive Vice President for Group Business & Strategic Development and Head for Water, Energy and Middle East & North Africa, as well as Prof Ng Wun Jern, Executive Director of NTU-NEWRI. The signing was also witnessed by the Economic Development Board's Director for Cleantech Goh Chee Kiong as well as Sembcorp Group President & CEO Tang Kin Fei. This agreement follows from an umbrella Master Research Collaboration Agreement formed between Sembcorp and NTU-NEWRI at last year's SIWW.

Commenting on the collaboration, Sembcorp Group President & CEO Mr Tang Kin Fei said, "We are happy to take our R&D collaboration with NTU-NEWRI a step further with this joint testbed for new wastewater treatment technology. This underscores Sembcorp's commitment to applying best available technology to meet our customers' water and wastewater treatment needs."

Elaborating on the technology to be explored, NTU's Associate Professor Volodymyr Ivanov, the Principal Investigator who leads the NTU team for the research collaboration, said, "NTU team has developed an innovative patented process, which is well suited for the treatment of industrial wastewater. This process models nature's way of cleaning the water. It is likely that this technology can be more competitive than other technologies. We are happy to collaborate with Sembcorp and develop this testbed and explore the technology further."

Remarking on the project, Professor Ng Wun Jern, Executive Director of NTU-NEWRI said. "Launched in 2008, NEWRI provides a clearly defined window through which industry and research partners can access NTU's comprehensive EWT capabilities. This partnership with Sembcorp is a good demonstration of NEWRI's goal of translating cutting-edge new water technology research and bringing it to an industry eager to benefit society and lead in an expanding market."


'/>"/>

Contact: Esther Ang
estherang@ntu.edu.sg
656-790-6804
Nanyang Technological University
Source:Eurekalert

Related medicine news :

1. PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File
2. Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd.
3. 3rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide, Inc.
4. XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market
5. U.S. Preventive Medicine(R), The Mount Sinai Medical Center Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services
6. Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation
7. U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia
8. Sisters of Charity Health System & University Hospitals Announce New Agreement for Jointly Owned Hospitals
9. ASH and EHA jointly announce translational research training in hematology program
10. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
11. New research explores newborn in-hospital weight loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , ... March 01, 2017 , ... ... healing grace in the lives of those who hear His voice. “Cleansing Thoughts; ... a retired Christian bookstore proprietor who enjoys boating, gardening and crocheting baby items ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Letter of Love”: a tale of young love ... survivor of the Civil War in El Salvador, wife, mother, and co-founder of a ... I dedicated myself to serve in very poor communities, and I study psychology. I ...
(Date:3/1/2017)... DENVER, Colo. (PRWEB) , ... March 01, 2017 ... ... solutions to the marijuana industry, today unveiled its Cannabis Compliance Program for Regulatory ... legal medical marijuana industry to provide regulators with internal or outsourced compliance program ...
(Date:2/28/2017)... ... March 01, 2017 , ... ... of SmarterMe, a personal assistant for sales powered by an intelligent mobile platform ... work smarter. , SmarterMe is built grounds up keeping individual users in mind ...
(Date:2/28/2017)... CA (PRWEB) , ... February 28, 2017 , ... Answering ... Area, Orthogonal LLC will open a branch office in the Soma neighborhood ... growing Bay Area staff human factors, FDA regulatory and software systems architecture subject matter ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Calif. , March 1, 2017   Sun Chlorella ... about all things chlorella, is pleased to announce Non-GMO Project ... premium chlorella powder. Just in time for the ... in Anaheim, CA , Sun Chlorella Corp. ... all chlorella products, including: Sun Chlorella ...
(Date:3/1/2017)... 2017  Integrated Modular Design (IMD), a ... implementation of pre-fabricated healthcare products like bathroom ... seeks to lead the construction industry toward ... Fueled by their leading-edge pre-fabrication solutions, ... construction timelines and project risk, and increasing ...
(Date:3/1/2017)... 1, 2017  Global biotherapeutics leader CSL Behring ... ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as ... reatment with H izentra ® ).  The Phase ... safety and tolerability of two different doses of CSL ... Subcutaneous [Human]), compared with placebo, in the maintenance treatment ...
Breaking Medicine Technology: